Shawn Brown, MD
Psychiatry · Waddy, KYNPI 1609910108
Payments from drug & device makers
Across 692 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$2K
- Teva Pharmaceuticals USA, Inc.$1K
- Axsome Therapeutics, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$761
- plus $3K from 21 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 146 | $2,380 |
| AbbVie(2 entities) | 124 | $1,525 |
| Teva Pharmaceuticals USA, Inc. | 97 | $1,377 |
| Axsome Therapeutics, Inc. | 33 | $1,174 |
| Otsuka America Pharmaceutical, Inc. | 60 | $1,143 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 48 | $761 |
| Sunovion Pharmaceuticals Inc. | 51 | $651 |
| Vanda Pharmaceuticals Inc. | 22 | $502 |
| Alkermes, Inc. | 21 | $442 |
| Neurocrine Biosciences, Inc. | 20 | $371 |
| Lundbeck LLC | 20 | $268 |
| Biogen | 10 | $208 |
| Bausch Health US, LLC | 6 | $125 |
| Indivior Inc. | 6 | $118 |
| Harmony Biosciences LLC | 5 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| E.r. Squibb & Sons, L.L.C. | 2 | $57 |
| Ironshore Pharmaceuticals Inc. | 3 | $56 |
| Neuronetics, Inc. | 3 | $48 |
| Eisai Inc. | 3 | $42 |
| Bioxcel Therapeutics, Inc. | 2 | $41 |
| Sage Therapeutics, LLC | 2 | $32 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $29 |
| Almatica Pharma LLC | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Noven Therapeutics, LLC | 1 | $12 |
How this compares
$11,578 in reported general payments places this provider in the 90th percentile of 348 psychiatry providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Waddy
- Carmen PintoElizabethtown$1.7M
- Rifaat El-MallakhLouisville$1.7M
- Robert StewartLouisville$651K
- Mark WrightLexington$637K
- Carol MillerFrankfort$462K
- Ali FarooquiLouisville$393K
- Balakumar KrishnaswamyHazard$162K
- Steven CroleyLexington$151K
- Joseph HarrisonOwensboro$131K
- Stephanie HallLouisville$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.